Benitec Biopharma, Inc. (BNTC)
Benitec Biopharma Market Cap : 288.88M for Nov. 18, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 17, 2026 | 284.35M |
| November 16, 2026 | 297.95M |
| November 13, 2026 | 315.40M |
| November 12, 2026 | 317.14M |
| November 11, 2026 | 330.40M |
| November 10, 2026 | 323.77M |
| November 09, 2026 | 339.69M |
| November 06, 2026 | 328.34M |
| November 05, 2026 | 297.36M |
| November 04, 2026 | 319.39M |
| November 03, 2026 | 289.10M |
| November 02, 2026 | 292.20M |
| October 30, 2026 | 300.80M |
| October 29, 2026 | 303.90M |
| October 28, 2026 | 302.87M |
| October 27, 2026 | 298.74M |
| October 26, 2026 | 295.64M |
| October 23, 2026 | 297.71M |
| October 22, 2026 | 303.56M |
| October 21, 2026 | 292.54M |
| October 20, 2026 | 311.13M |
| October 19, 2026 | 287.72M |
| October 16, 2026 | 279.12M |
| October 15, 2026 | 291.17M |
| October 14, 2026 | 285.32M |
| Date | Value |
|---|---|
| October 13, 2026 | 297.02M |
| October 12, 2026 | 312.16M |
| October 09, 2026 | 305.28M |
| October 08, 2026 | 301.15M |
| October 07, 2026 | 309.41M |
| October 06, 2026 | 309.75M |
| October 05, 2026 | 317.67M |
| October 02, 2026 | 309.06M |
| October 01, 2026 | 329.71M |
| September 30, 2026 | 344.17M |
| September 29, 2026 | 335.56M |
| September 28, 2026 | 344.86M |
| September 25, 2026 | 330.06M |
| September 24, 2026 | 331.78M |
| September 23, 2026 | 338.32M |
| September 22, 2026 | 376.86M |
| September 21, 2026 | 374.45M |
| September 18, 2026 | 379.27M |
| September 17, 2026 | 390.97M |
| September 16, 2026 | 379.96M |
| September 15, 2026 | 380.31M |
| September 14, 2026 | 415.75M |
| September 11, 2026 | 419.54M |
| September 10, 2026 | 420.57M |
| September 09, 2026 | 427.71M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Alnylam Pharmaceuticals, Inc. | 20.01B |
| Ionis Pharmaceuticals, Inc. | 4.556B |
| ACADIA Pharmaceuticals, Inc. | 3.082B |
| Anika Therapeutics, Inc. | 182.43M |
| Savara, Inc. | 973.21M |
Market Cap Related Metrics
| PEG Ratio | -1.098 |
| Price to Book Value | 1.703 |
| Price | 8.28 |
| Earnings Yield | -13.68% |
| PEGY Ratio | -1.098 |